In Part 1 of this 3-part series, we will explore how our first E, Engagement, can be used to build patient trust.
Patient engagement is often mistaken for patient recruitment. They are not the same thing. Finding people is not the same as keeping them, and a signed consent form is where engagement starts rather than where it ends. It is a commitment that lasts through every step of the clinical trial journey. When done well, it creates lasting trust between research teams and the people they depend on most: patients.
Building this trust requires more than protocols and consent forms. It calls for a mindset shift. Patients must be seen not as subjects but as people with lives, needs, and questions. Engagement that builds trust is about consistent communication, thoughtful support, and creating a sense of shared purpose.
Many clinical trial teams are working hard to include patient voices. Inclusion alone, though, is not engagement. It takes active listening and meaningful follow-through. Patients are more likely to stay involved when they feel heard and respected. Their time matters. Their experiences matter. So does the way they are treated throughout the process.
One of the most overlooked patient engagement strategies is simple: asking patients how they want to be involved. Whether it’s offering flexible visit options or translating materials into simpler language, real engagement means meeting people where they are. These efforts send a powerful message that the research team is invested in their comfort and success.
Understanding What Patients Experience
Trust is built when trial teams understand what patients go through. From diagnosis to the decision to join a study, each step carries weight. Patients may feel overwhelmed, uncertain, or even scared. By recognizing these emotions, sponsors and sites can create trial experiences that support and reassure instead of confuse or isolate.
This starts with practical details. How easy is it to travel to the site? Are instructions clear and friendly? Are follow-ups timely and human? Every interaction matters. When patients face a wall of silence or a lack of clarity, it chips away at trust. On the other hand, simple efforts (a quick call to confirm an appointment or a thank-you message after a visit) show that the patient matters beyond the data they provide.
Understanding the patient journey also means acknowledging that people have responsibilities outside the trial. Work, family, and financial concerns affect whether someone can take part in a study. Supporting these realities, by reimbursing travel or offering weekend visits, makes trials more accessible and shows respect for the patient as a whole person.
Why Communication Must Feel Human
The language used in clinical trials is often complicated. Terms that make sense to researchers can confuse patients. If patients are going to engage fully, they need to understand what’s being asked of them, what to expect, and why their role is valuable.
Clear and human communication helps bridge this gap. Instead of dense brochures, consider using visual aids, short videos, or in-person walkthroughs. Instead of generic check-ins, try personalized messages that acknowledge the patient’s contributions. These efforts are not extra. They are essential. They help patients feel safe, seen, and informed.
Feedback is also part of communication. Patients who provide input should hear how their feedback influenced the trial. If a concern was raised and addressed, tell them. If not, explain why. Being transparent strengthens the relationship and keeps patients engaged. They feel like partners, not just participants.
Creating a Sense of Belonging
Belonging might not sound like a scientific priority, but it’s at the heart of trust. When patients feel like they are part of something important, they are more motivated and committed. A sense of purpose boosts retention and builds lasting relationships with trial teams.
This feeling can be fostered in many ways. One is visibility. Show patients how their role contributes to the bigger picture. Share trial updates or milestones. Celebrate when goals are met. Another is community. Connect patients with others in the study if they choose. Knowing they are not alone can reduce anxiety and create shared support.
Personal touches make a difference too. A follow-up note, a reminder call that includes the patient’s name, or a thank-you card sent after the trial ends don’t take much time but build strong emotional connections. They show that the patient is valued for more than just their data.
Patient Engagement Strategies: How to Improve Patient Engagement in Clinical Trials
Engagement is not a single tool. It is a collection of actions, decisions, and attitudes that work together to support the patient experience. This means every member of the trial team needs to be aligned. From recruiters to nurses to data managers, everyone plays a role in creating trust.
Teams can demonstrate how to improve patient engagement in clinical trials by reviewing their touchpoints with patients. Are materials written clearly? Are updates consistent? Is there a way for patients to give feedback? Even small changes can make a big impact.
Training is another key step. Staff who understand the value of engagement are more likely to communicate with empathy. That empathy leads to stronger relationships, and stronger relationships mean patients who keep their visits, report problems early, and stay to the end.
Technology can also support engagement. Text reminders, patient portals, and secure messaging tools help patients stay connected and informed. These tools must be paired with a human approach, though. No system can replace the value of a personal interaction.
It is worth remembering that engagement is ongoing. What works at the start of a trial may need adjustment later. Continuous improvement based on patient feedback is vital. So is flexibility. Not every patient will need the same level of contact or support. Tailoring the approach builds better experiences for everyone.
True engagement takes effort, but the return is well worth it. When patients trust their trial teams, they stay involved, provide better data, and advocate for future participation. Everyone wins.
Engagement that builds trust starts before the first visit, with people who understand what they are agreeing to. See what trialport does for sponsors and CROs.
About the author
Keith Berelowitz has spent more than twenty years watching clinical trials work on paper and struggle in real life. He has helped run studies, advises sponsors and CROs on how they engage with people, and chairs a UK research ethics committee, where consent forms and participant information sheets cross his desk every month. That vantage point led to one conclusion: most trial problems are not failures of science. They are failures of understanding at the moment a person decides.
He founded trialport, a clinical trial navigation and decision-support platform, so that understanding a study comes before anyone is asked to join one. Understanding comes first. Decisions follow.